The DOI matches its Crossref record.
Localization of low density lipoprotein receptors on plasma membrane of normal human fibroblasts and their absence in cells from a familial hypercholesterolemia homozygote
Abstract
Monolayers of normal human fibroblasts were observed to bind ferritin-labeled low density lipoprotein (LDL-ferritin) at specific receptor sites on the cell surface membrane. When fibroblasts were incubated with LDL-ferritin at 4 degrees, more than 70% of the surface-bound ferritin cores were localized by electron microscopy to short segments of the plasma membrane where the membrane appeared indented and coated on both of its sides by a fuzzy material. These membrane segments corresponded to "coated regions" previously described in other cell types. Unver the conditions of these experiments, an average of 55 LDL-ferritin particles were bound to each millimeter of plasma membrane in normal cells. In the presence of a 15-fold excess of native LDL, the number of bound ferritin cores was reduced by 75%, suggesting that the LDL-ferritin was binding to specific LDL receptor sites. Although fibroblasts from a patient with the homozygous form of familial hypercholesterolemia contained the same number of indented, coated membrane regions per millimeter of cell surface as did normal cells, no LDL-ferritin was observed to bind to the cell membrane in these mutant cells. The present ultrastructural data are consistent with previous biochemical and genetic evidence indicating that LDL exerts its regulatory action on cellular cholesterol metabolism in fibroblasts through an interaction with a specific cell surface receptor and that this receptor is defective in homozygous familial hypercholesterolemia fibroblasts. Moreover, the data suggest that the LDL receptor is localized to indented, coated regions of the plasma membrane that appear to participate in the adsorptive endocytosis of proteins.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
LDLR can be re-used 100 times after its endocytosis into the endosomal network.
“can be re-used 100 times after its endocytosis into endosomal network.28”
From A common variant in CCDC93 protects against myocardial infarction and cardiovascular mortality by regulating endosomal trafficking of low-density lipoprotein receptor (2020) · cites this paper as [28]
The Discussion describes LDL-ferritin being ingested through coated pits, but does not say that LDL receptors enter an endosomal network or are reused. Searches for receptor recycling and “100 times” found no passage supporting the claimed reuse count. (LLM, conf=0.74)
Experimental — accuracy not yet measuredThe LDLR can be re-used up to 100 times after its internalization into early endosomes.
“Central to the current study is that Goldstein and Brown also reported that the LDLR can be re-used up to 100 times after its internalization into early endosomes.28”
From A common variant in CCDC93 protects against myocardial infarction and cardiovascular mortality by regulating endosomal trafficking of low-density lipoprotein receptor (2020) · cites this paper as [28]
The Discussion describes LDL-ferritin entering cells through coated vesicles, but does not say that LDL receptors are internalized and reused. Searches for receptor recycling, early endosomes, and “100 times” found no supporting passage in our copy. (LLM, conf=0.76)
Experimental — accuracy not yet measuredLDLR is the central regulator of plasma levels of LDL cholesterol.
“Low-density lipoprotein-receptor is the central regulator of plasma levels of low-density lipoprotein cholesterol”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 9
- [3]Brown, M. S. & Goldstein, J. L. (1974) Proc. Natl. Acad. Sci. USA 71, 788–792.
- [2]Goldstein, J. L. & Brown, M. S. (1976) in Current Topics in Cellular Regulation, eds. Horecker, B. L. & Stadtman, E. R. (Academic Press, New York), Vol. 11, in press.
- [6]Brown, M. S., Dana, S. E. & Goldstein, J. L. (1975) Proc. Natl. Acad. Sci. USA 72, 2925–2929.
- [8]Goldstein, J. L., Dana, S. E. & Brown, M. S. (1974) Proc. Natl. Acad. Sci. USA 71, 4288–4292.
- [10]Goldstein, J. L., Dana, S. E., Brunschede, G. Y. & Brown, M. S. (1975) Proc. Natl. Acad. Sci. USA 72, 1092–1096.
- [18]Bennett, H. S. (1969) in Handbook of Molecular Cytology, ed., Lima-de Faria, A. (North Holland Publishing Co., Amsterdam), pp. 1294–1319.
- [19]Stein, O., Weinstein, D. B., Stein, Y. & Steinberg, D. (1976) Proc. Natl. Acad. Sci. USA 73, 14–18.
- [20]Brown, M. S., Ho, Y. K. & Goldstein, J. L. (1976) Ann. N.Y. Acad. Sci., in press.
- [23]Korn, E. D. (1975) in Biochemistry of Cell Walls and Membranes, ed. Fox, C. F. (MTP International Review of Science, London), Vol. 2, pp. 1–26.
Cited by
Sorted by citations
A Receptor-Mediated Pathway for Cholesterol Homeostasis
Brown, M. S., & Goldstein, J. L. (1986) · Science · doi:10.1126/science.3513311 · Cited by 5,703
Self-citationBROWN, M. S., KOVANEN, P. T., & GOLDSTEIN, J. L. (1979) · Proceedings of the 1978 Laurentian Hormone Conference · doi:10.1016/b978-0-12-571135-7.50009-6 · Cited by 311
Self-citationTHE LDL RECEPTOR LOCUS AND THE GENETICS OF FAMILIAL HYPERCHOLESTEROLEMIA
Goldstein, J. L., & Brown, M. S. (1979) · Annual Review of Genetics · doi:10.1146/annurev.ge.13.120179.001355 · Cited by 233
Self-citationRegarding the Amazing Choreography of Clathrin Coats
Traub, L. M. (2011) · PLoS Biology · doi:10.1371/journal.pbio.1001037 · Cited by 73
Harnessing RNA Interference for Cholesterol Lowering: The Bench‐to‐Bedside Story of Inclisiran
Wilkinson, M. J., Bajaj, A., Brousseau, M. E., & Taub, P. R. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.123.032031 · Cited by 37
Modulation of blood cell gene expression by DHA supplementation in hypertriglyceridemic men
Dawson, K., Zhao, L., Adkins, Y., Vemuri, M., Rodriguez, R. L., Gregg, J. P., Kelley, D. S., & Hwang, D. H. (2012) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2011.03.004 · Cited by 24
Rimbert, A., Dalila, N., Wolters, J. C., Huijkman, N., Smit, M., Kloosterhuis, N., Riemsma, M., van der Veen, Y., Singla, A., van Dijk, F., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz727 · Cited by 24
Metadata
- Authors
- Anderson, R. G., Goldstein, J. L., & Brown, M. S.
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 1976-07
- Volume
- 73
- Issue
- 7
- Pages
- 2434-2438
- ISSN
- 0027-8424
- 1091-6490
- Cited by
- 186
- References
- 0
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review